Stockscreener 앱 받기
1.93
7.22%
0.13
시장 영업 전:
1.91
-0.02
-1.04%
Pepgen Inc 주식(PEPG)의 최신 뉴스
Pictet Asset Management Holding SA Purchases 871,059 Shares of PepGen, Inc. $PEPG - MarketBeat
Stifel reiterates Buy on PepGen stock amid partial clinical hold - Investing.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - ChartMill
PepGen crashes after mid-stage trial data for muscle disorder therapy - MSN
Pomerantz Law Firm Investigates Claims On Behalf of Investors of PepGen Inc.PEPG - FinancialContent
[ARS] PepGen Inc. SEC Filing - Stock Titan
PepGen (NASDAQ: PEPG) details 2026 virtual meeting and auditor vote - Stock Titan
PepGen advances momentum with Palo Alto meeting on DM1 community engagement - Traders Union
PepGen shares slide 20% as FDA clinical hold overshadows earnings beat - MSN
Wedbush Maintains PepGen (PEPG) Outperform Recommendation - MSN
PepGen Inc. tops EPS estimates by 29.3%, narrower loss no revenueReal Trader Insights - Cổng thông tin điện tử tỉnh Lào Cai
PepGen’s stock up 120% on DM1 trial success - MSN
Peptide Drug Conjugate Market Landscape Report 2026: A $1.5 Billion Opportunity by 2031 - GlobeNewswire Inc.
PEPG Stock Price, Quote & Chart | PEPGEN INC (NASDAQ:PEPG) - ChartMill
PepGen (PEPG) Stock: Sentiment Overview (Bearish Sentiment) 2026-04-16Attention Driven Stocks - Cổng thông tin điện tử tỉnh Tây Ninh
PEPG News | PEPGEN INC (NASDAQ:PEPG) - ChartMill
Biotech Firm PepGen Receives 'Moderate Buy' Rating from Analysts - National Today
PepGen, Inc. (NASDAQ:PEPG) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
PepGen: Modest FREEDOM2 Efficacy, Regulatory Overhang, and Competitive Pressures Underscore Sell Rating - TipRanks
Signal Recap: Should I set a stop loss on PepGen Inc2026 Pullback Review & Technical Confirmation Alerts - baoquankhu1.vn
PepGen team joins Kansas City event to drive myotonic dystrophy research discussions - Traders Union
Rate Cut: Does PepGen Inc have declining or rising EPSAnalyst Upgrade & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
PepGen joins MyotonicStrong conference to present clinical progress - Traders Union
Top 3 Health Care Stocks Which Could Blast Off This Quarter - Benzinga
PEPG Q4 2025 Earnings: PepGen Inc. Beats EPS Estimates, No Revenue PostedHot Momentum Watchlist - Cổng thông tin điện tử tỉnh Lào Cai
Retail Trends: Is PepGen Inc forming a breakout pattern2026 Chart Watch & Long Hold Capital Preservation Tips - baoquankhu1.vn
Published on: 2026-04-07 21:04:49 - baoquankhu1.vn
PEPG.O Technical Analysis & Stock Price Forecast - Intellectia AI
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
PEPG Technical Analysis & Stock Price Forecast - Intellectia AI
PepGen stock plunges 26% on FDA partial clinical hold - Investing.com
PepGen Reports Encouraging Phase II FREEDOM2 DM1 Data at 5 mg/kg; 10 mg/kg Cohort Underway - National Today
Biopharma bites: PepGen's partial pause, Roche's Korea investment, plus Teva's financing - FirstWord Pharma
FDA places partial clinical hold on PepGen’s DM1 trial - Investing.com
Scholar Rock To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday - Sahm
Assay what? Eyes on Pepgen’s vim-sapping DM1 phase II - BioWorld MedTech
Buy Rating on PepGen: DM1 Program De-Risked by Stronger Underlying Biology and Upside from Higher-Dose Cohorts - TipRanks
PEPG: FREEDOM2's 5 mg/kg cohort showed promising safety and efficacy, supporting dose escalation - TradingView — Track All Markets
MACD Signal: What are the analyst revisions for NEOVIs PepGen Inc stock a good investment in YEAR2026 Volatility Report & Growth Focused Stock Reports - baoquankhu1.vn
0.14%
0.48%
자본화:
|
볼륨(24시간):